Huang J - Search Results

1

Clinical and immunological characteristics of vaccinated patients with COVID-19.

Ping Y, Huang J, Fan F, Guo Y, Gou J, Zhang Y. Ping Y, et al. Among authors: huang j. Chin Med J (Engl). 2022 Jul 20;135(14):1756-1758. doi: 10.1097/CM9.0000000000002267. Chin Med J (Engl). 2022. PMID: 35984113 Free PMC article. No abstract available.

2

Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma.

Zhao X, Zhang Z, Li H, Huang J, Yang S, Xie T, Huang L, Yue D, Xu L, Wang L, Zhang W, Zhang Y. Zhao X, et al. Among authors: huang l, huang j. Cancer Lett. 2015 Jul 1;362(2):192-8. doi: 10.1016/j.canlet.2015.03.043. Epub 2015 Apr 2. Cancer Lett. 2015. PMID: 25843292 Clinical Trial.

3

Efficacy and safety of cord blood-derived cytokine-induced killer cells in treatment of patients with malignancies.

Zhang Z, Wang L, Luo Z, Zhao X, Huang J, Li H, Yang S, Zhao X, Zhang L, Li L, Wang F, Huang L, Zhang Y. Zhang Z, et al. Among authors: huang l, huang j. Cytotherapy. 2015 Aug;17(8):1130-8. doi: 10.1016/j.jcyt.2015.04.002. Epub 2015 May 9. Cytotherapy. 2015. PMID: 25963952 Clinical Trial.

4

Selective effect of cytokine-induced killer cells on survival of patients with early-stage melanoma.

Li H, Huang L, Liu L, Wang X, Zhang Z, Yue D, He W, Fu K, Guo X, Huang J, Zhao X, Zhu Y, Wang L, Dong W, Yan Y, Xu L, Gao M, Yang S, Zhang Y. Li H, et al. Among authors: huang l, huang j. Cancer Immunol Immunother. 2017 Mar;66(3):299-308. doi: 10.1007/s00262-016-1939-x. Epub 2016 Nov 26. Cancer Immunol Immunother. 2017. PMID: 27889798 Free PMC article.

5

Chemotherapy in combination with cytokine-induced killer cell transfusion: An effective therapeutic option for patients with extensive stage small cell lung cancer.

Huang J, Kan Q, Lan, Zhao X, Zhang Z, Yang S, Li H, Wang L, Xu L, Cheng Z, Zhang Y. Huang J, et al. Int Immunopharmacol. 2017 May;46:170-177. doi: 10.1016/j.intimp.2016.12.005. Epub 2017 Mar 12. Int Immunopharmacol. 2017. PMID: 28292730

6

CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer.

Li J, Wang L, Chen X, Li L, Li Y, Ping Y, Huang L, Yue D, Zhang Z, Wang F, Li F, Yang L, Huang J, Yang S, Li H, Zhao X, Dong W, Yan Y, Zhao S, Huang B, Zhang B, Zhang Y. Li J, et al. Among authors: huang l, huang b, huang j. Oncoimmunology. 2017 Apr 21;6(6):e1320011. doi: 10.1080/2162402X.2017.1320011. eCollection 2017. Oncoimmunology. 2017. PMID: 28680754 Free PMC article.

7

Pseudomonas aeruginosa-mannose sensitive hemagglutinin injection treated cytokine-induced killer cells combined with chemotherapy in the treatment of malignancies.

Zhang C, Zhang Z, Wang L, Han J, Li F, Shen C, Li H, Huang L, Zhao X, Yue D, Huang J, Yan Y, Zhang Y. Zhang C, et al. Among authors: huang l, huang j. Int Immunopharmacol. 2017 Oct;51:57-65. doi: 10.1016/j.intimp.2017.08.003. Epub 2017 Aug 10. Int Immunopharmacol. 2017. PMID: 28802902

8

Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer.

Li L, Wang L, Li J, Fan Z, Yang L, Zhang Z, Zhang C, Yue D, Qin G, Zhang T, Li F, Chen X, Ping Y, Wang D, Gao Q, He Q, Huang L, Li H, Huang J, Zhao X, Xue W, Sun Z, Lu J, Yu JJ, Zhao J, Zhang B, Zhang Y. Li L, et al. Among authors: huang l, huang j. Cancer Res. 2018 Apr 1;78(7):1779-1791. doi: 10.1158/0008-5472.CAN-17-2460. Epub 2018 Jan 26. Cancer Res. 2018. PMID: 29374065 Free PMC article.

9

Maelstrom Directs Myeloid-Derived Suppressor Cells to Promote Esophageal Squamous Cell Carcinoma Progression via Activation of the Akt1/RelA/IL8 Signaling Pathway.

Li P, Chen X, Qin G, Yue D, Zhang Z, Ping Y, Wang D, Zhao X, Song M, Zhao Q, Li J, Liu S, Wang D, Zhang C, Lian J, Cao L, Li F, Huang L, Wang L, Yang L, Huang J, Li H, Zhang B, Zhang Y. Li P, et al. Among authors: huang l, huang j. Cancer Immunol Res. 2018 Oct;6(10):1246-1259. doi: 10.1158/2326-6066.CIR-17-0415. Epub 2018 Aug 6. Cancer Immunol Res. 2018. PMID: 30082413

10

Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy.

Liu Y, Chen X, Wang D, Li H, Huang J, Zhang Z, Qiao Y, Zhang H, Zeng Y, Tang C, Yang S, Wan X, Chen YH, Zhang Y. Liu Y, et al. Among authors: huang j. J Immunother. 2018 Nov/Dec;41(9):406-410. doi: 10.1097/CJI.0000000000000243. J Immunother. 2018. PMID: 30198955 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54,022 results

Search Page